The TCGA database depicted decreased survival in liver cancer patients with altered RASSF1. However, literature also evidenced the reverse findings that RASSF1A hypermethylation results in longer OS in HCC patients69. This evidence concerns the gene RASSF1 and hepatocellular carcinoma.